Search Login Register

Angiotensin II Summary

Description: An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.

Also Known As: 5-L-Isoleucine Angiotensin II; ANG-(1-8)Octapeptide; Angiotensin II, Isoleucine(5)-; Angiotensin II, Valine(5)-; Angiotensin-(1-8) Octapeptide Show All >>

Networked: 10133 relevant articles (315 outcomes, 1327 trials/studies) for this Bio-Agent

Key Diseases for which Angiotensin II is Relevant

  1. Hypertension (High Blood Pressure) : 96 outcomes 366 studies in 2941 results
  2. Heart Failure : 29 outcomes 83 studies in 647 results
  3. Fibrosis (Cirrhosis) : 22 outcomes 85 studies in 691 results
  4. Cardiomegaly (Heart Hypertrophy) : 14 outcomes 56 studies in 456 results
  5. Diabetic Nephropathies (Diabetic Nephropathy) : 14 outcomes 55 studies in 193 results
Show All >>

Drugs Related to Angiotensin II

  1. Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
  2. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
  3. Losartan (Cozaar)
  4. Renin
  5. Captopril (Capoten)
  6. Angiotensin Receptor Antagonists
  7. Aldosterone
  8. Norepinephrine (Noradrenaline)
  9. Sodium
  10. Insulin (Novolin)
Show All >>

Therapies Related to Angiotensin II

  1. Drug Therapy (Chemotherapy)
  2. Transplants (Transplant)
  3. Intra-Arterial Infusions
  4. Injections
  5. Microspheres (Microsphere)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.